Ultrasound surgery to determine the advantages of uterine fibroids were confirmed

Chongqing Medical University, National Medical Engineering Research Center led the "second five" national support program research - "ultrasound ablation of uterine fibroids of the prospective, multi-center, non-random parallel control over the same period" results show that focused ultrasound surgery (HIFU) treatment of uterine fibroids is not less effective than traditional surgery, and safety is significantly better than traditional surgery, and can improve the quality of life of patients, shorten the length of stay, save health care costs. The research paper has been published in the British Journal of Obstetrics and Gynecology. The subject of the subject, Chongqing Medical University Professor Chen Wenzhe introduction, which is by far the world's largest, through the World Health Organization registered platform registered HIFU treatment of uterine fibroids multi-center clinical study. The study was conducted under the guidance and supervision of the Chinese Evidence-Based Medicine Center in West China College of Clinical Medicine, Sichuan University, according to the clinical trials of IDEAL complex surgery in Oxford University, UK, covering 20 hospitals. Of the 2411 patients enrolled in the study, 1353 were treated with HIFU, 472 underwent hysterectomy, and 586 received uterine myoma.

Meilun According to reports, compared with the surgical treatment, HIFU 6 months after treatment, uterine fibroids symptoms and quality of life are improved faster. The incidence of severe adverse events in the HIFU group was 0.2%, 12.6% in the surgery group and significantly lower in the HIFU group than in the surgery group. HIFU treatment after hospitalization for 4 days, hysterectomy total hospitalization time of 10 days, uterine myoma removal of the hospitalization time of 8 days, in shortening the hospital time also has obvious advantages.

In the past 20 years, China has been leading the development and clinical application of HIFU technology, but due to the lack of systematic, high-quality clinical evaluation evidence, a serious impediment to the surgical new technology of the world Promotion, and this study marks a leap in HIFU's Chinese clinical research - providing high-quality evidence-based medicine.

Chinese Medical Association, Chongqing Medical University and the Chinese Medical Association Obstetrics and Gynecology Branch recently held a joint conference to introduce the results. According to reports, uterine fibroids are women's common gynecological tumor disease, the world has 330 million patients with uterine fibroids in China each year 1.5 million cases of uterine fibroids in patients with uterine cancer was removed, its physical and mental health hazards it goes without saying. HIFU treatment technology is China's original, the world's leading technology.